BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22902443)

  • 1. [Examination of factors influencing continuity of S-1 adjuvant chemotherapy for gastric cancer patients].
    Kawabata R; Imamura H; Kishimoto T; Hachino Y; Yasui Y; Fujino M; Fujii C; Fukunaga M; Ohzato H; Furukawa H
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1205-8. PubMed ID: 22902443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Examination of continuity of S-1 adjuvant chemotherapy for gastric cancer patients after gastrectomy].
    Kawabata R; Imamura H; Kishimoto T; Anami S; Yasui Y; Fujino M; Fujii C; Sumida R; Furukawa H
    Gan To Kagaku Ryoho; 2011 May; 38(5):793-5. PubMed ID: 21566439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
    Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous administration and safety of S-1 in adjuvant chemotherapy for gastric cancer].
    Kimura M; Morihata K; Ito D; Iwai M; Okada K; Usami E; Nakao T; Yoshimura T; Yasuda T
    Gan To Kagaku Ryoho; 2010 May; 37(5):829-34. PubMed ID: 20495311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
    Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
    N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
    Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
    Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.
    Jeong JH; Ryu MH; Ryoo BY; Lee SS; Park I; Lee SH; Kim KC; Yook JH; Oh ST; Kim BS; Kang YK
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):523-9. PubMed ID: 22864947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].
    Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of adjuvant chemotherapy with S-1 for gastric cancer patients].
    Kitagawa M; Ichikawa D; Okamoto K; Shiozaki A; Fujiwara H; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1917-9. PubMed ID: 20948256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
    Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
    Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
    Aoyama T; Yoshikawa T; Shirai J; Hayashi T; Yamada T; Tsuchida K; Hasegawa S; Cho H; Yukawa N; Oshima T; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Jun; 20(6):2000-6. PubMed ID: 23242818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
    Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of liaison-clinical pathway for patients with gastric cancer undergoing adjuvant chemotherapy using S-1 after curative gastrectomy].
    Imamura H; Anami S; Watanabe M; Kishimoto T; Miyazaki Y; Kato H; Usui T; Masutani S; Tomotsu K; Furukawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1361-5. PubMed ID: 18701849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of S-1 for stage IV gastric cancer].
    Kanazawa Y; Furukawa K; Yamada T; Shirakawa T; Fujita I; Kato S; Yokoi K; Uchida E
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1619-22. PubMed ID: 21996955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present state and prospects of adjuvant chemotherapy for gastric cancer].
    Hori T; Ozawa R; Hanayama H; Yamashita H; Kaibe N; Matsumoto T; Oshima T; Takemura M; Kikuchi S; Sasako M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1390-5. PubMed ID: 21918333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
    Fujitani K; Tsujinaka T; Hirao M
    Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative adjuvant chemotherapy for gastric cancer after the adjuvant chemotherapy trial of S-1 for gastric cancer in Hiroshima prefecture: results from a questionnaire survey and future challenges].
    Yamaguchi K; Hirabayashi N; Ninomiya M; Shinozaki K; Hatanaka N; Matsuda H; Tanabe K
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2555-9. PubMed ID: 24335369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.